Medical Polyoxymethylene (POM) Market

By Type;

Homopolymer POM and Copolymer POM

By Application;

Dialysis Machine, Handles For Surgical Instruments, Inhalers, Insulin Pen, Medical Trays, Pharmaceutical Closures and Others

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn115167484 Published Date: September, 2025 Updated Date: October, 2025

Medical Polyoxymethylene (Pom) Market Overview

Medical Polyoxymethylene (Pom) Market (USD Million)

Medical Polyoxymethylene (Pom) Market was valued at USD 74.93 million in the year 2024. The size of this market is expected to increase to USD 99.94 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 4.2%.


Medical Polyoxymethylene (POM) Market

*Market size in USD million

CAGR 4.2 %


Study Period2025 - 2031
Base Year2024
CAGR (%)4.2 %
Market Size (2024)USD 74.93 Million
Market Size (2031)USD 99.94 Million
Market ConcentrationHigh
Report Pages311
74.93
2024
99.94
2031

Major Players

  • Celanese Corporation
  • BASF SE
  • DuPont
  • LG Chem
  • Asahi Kasei Corporation
  • Mitsubishi Engineering-Plastics Corporation
  • Polyplastics Co., Ltd
  • Kolon Plastics, Inc
  • Yunnan Yuntianhua Co., Ltd
  • Formosa Plastics Corporation

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Medical Polyoxymethylene (POM) Market

Fragmented - Highly competitive market without dominant players


The Medical Polyoxymethylene (POM) Market is expanding rapidly as healthcare providers seek high-performance materials for medical devices. Known for its strength, durability, and resistance to harsh conditions, POM is increasingly replacing conventional plastics. Adoption has risen by almost 32%, as its ability to ensure reliability in demanding healthcare settings makes it indispensable.

Growth Drivers and Opportunities
The increasing reliance on durable medical polymers is a major factor driving demand. Nearly 40% of device manufacturers now integrate POM into surgical tools, fluid delivery devices, and other precision instruments. Its compatibility with sterilization methods and precision requirements positions it as a vital choice for next-generation medical technologies.

Innovation Strengthening the Market
Technological improvements in polymer processing and biocompatibility are broadening POM’s role in healthcare. Around 45% of innovations target cost reduction and enhanced safety, making it suitable for orthopedic implants and diagnostic equipment. These enhancements ensure compliance with stringent healthcare regulations while enabling faster market penetration.

Collaborations Shaping Market Expansion
Strategic alliances between material developers and device manufacturers are paving the way for eco-friendly and performance-driven POM solutions. More than 38% of partnerships are directed toward sustainable development and rapid commercialization. These collaborations create opportunities for faster innovation cycles and stronger industry-wide adoption.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Type
    2. Market Snapshot, By Application
    3. Market Snapshot, By Region
  4. Medical Polyoxymethylene (POM) Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Growing healthcare expenditure
        2. Advancements in medical technology
        3. Rising geriatric population
        4. Increasing demand for disposable medical devices
      2. Restraints
        1. High raw material costs
        2. Stringent regulatory requirements
        3. Environmental concerns
        4. Market competition from alternatives
      3. Opportunities
        1. Technological innovations
        2. Emerging markets expansion
        3. Rising demand for biocompatible materials
        4. Increased R&D investments
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Medical Polyoxymethylene (POM) Market, By Type, 2021 - 2031 (USD Million)
      1. Homopolymer POM
      2. Copolymer POM
    2. Medical Polyoxymethylene (POM) Market, By Application, 2021 - 2031 (USD Million)
      1. Dialysis Machine
      2. Handles For Surgical Instruments
      3. Inhalers
      4. Insulin Pen
      5. Medical Trays
      6. Pharmaceutical Closures
      7. Others
    3. Medical Polyoxymethylene (POM) Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Celanese Corporation
      2. DuPont de Nemours, Inc.
      3. Polyplastics Co., Ltd. (Daicel Corporation)
      4. Mitsubishi Engineering-Plastics Corporation
      5. KEM ONE Group
      6. Ticona Engineering Polymers (a Celanese Business)
      7. LG Chem Ltd.
      8. Asahi Kasei Corporation
      9. BASF SE
      10. Kolon Plastics Inc.
      11. Formosa Plastics Corporation
      12. Ensinger GmbH
      13. Shanghai Bluestar POM Co., Ltd. (China National Bluestar Group)
      14. DuBay Polymer GmbH (joint venture of DuPont and BASF)
      15. Chang Chun Group
  7. Analyst Views
  8. Future Outlook of the Market